Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed8

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT04024059Not ApplicableCompleted
Contingency Management to Enhance Office-Based Buprenorphine Treatment
Opioid-use Disorder
PrincipalinvestigatorStart date: 2020-01-31
NCT03519009Not ApplicableCompleted
A Therapeutic Workplace to Address Poverty and Substance Use
Substance Use Disorders
PrincipalinvestigatorStart date: 2019-01-02
NCT00684788Phase 2Completed
Employment-Based Depot Naltrexone Clinical Trial
Opiate Dependence
PrincipalinvestigatorStart date: 2006-05-01
NCT00149669Not ApplicableCompleted
Employment-based Reinforcement of Naltrexone Ingestion and Abstinence
Cocaine-Related DisordersHeroin DependenceOpioid-Related Disorders+1 more
Principalinvestigator
NCT00249457Not ApplicableCompleted
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
Behavior, AddictiveCocaine AbuseCocaine Dependence+2 more
Principalinvestigator
NCT00249470Not ApplicableCompleted
The Therapeutic Workplace Initiation Study
Cocaine-Related DisordersHeroin DependenceOpioid-Related Disorders+1 more
Principalinvestigator
NCT00249496Not ApplicableCompleted
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
Alcohol UseDrug UseRisk Behavior+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid Use DisorderDrug UseOpioid-Related Disorders+1 more
Similarity Score9%

Rajita Sinha, PhD

Yale University

Related
11 trials

Shared therapeutic areas:

Cocaine DependenceOpioid-Related DisordersOpioid Use Disorder+1 more

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA)
Similarity Score9%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related DisordersOpioid Use Disorder+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine DependenceCocaine-Related Disorders+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Colleen A Hanlon, PhD

Medical University of South Carolina

Related
9 trials

Shared therapeutic areas:

Cocaine DependenceOpioid-Related DisordersSubstance Use Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Related
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersHeroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score7%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score5%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)
Similarity Score5%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

Johns Hopkins UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)+1 more
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT04024059Not ApplicablePrincipalInvestigator

Contingency Management to Enhance Office-Based Buprenorphine Treatment

Opioid-use Disorder
Completed
NCT03519009Not ApplicablePrincipalInvestigator

A Therapeutic Workplace to Address Poverty and Substance Use

Substance Use Disorders
Completed
NCT01556425Phase 2PrincipalInvestigator

The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence

Opioid Dependence
Completed
NCT00684788Phase 2PrincipalInvestigator

Employment-Based Depot Naltrexone Clinical Trial

Opiate Dependence
Completed
NCT00149669Not ApplicablePrincipalInvestigator

Employment-based Reinforcement of Naltrexone Ingestion and Abstinence

Cocaine-Related DisordersHeroin DependenceOpioid-Related Disorders+1 more
Completed
NCT00249457Not ApplicablePrincipalInvestigator

Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2

Behavior, AddictiveCocaine AbuseCocaine Dependence+2 more
Completed
NCT00249470Not ApplicablePrincipalInvestigator

The Therapeutic Workplace Initiation Study

Cocaine-Related DisordersHeroin DependenceOpioid-Related Disorders+1 more
Completed
NCT00249496Not ApplicablePrincipalInvestigator

Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1

Alcohol UseDrug UseRisk Behavior+1 more
Completed

All 8 trials loaded